These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2265462)

  • 1. DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).
    Pendyala L; Arakali AV; Sansone P; Cowens JW; Creaven PJ
    Cancer Chemother Pharmacol; 1990; 27(3):248-50. PubMed ID: 2265462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans.
    Pendyala L; Cowens JW; Chheda GB; Dutta SP; Creaven PJ
    Cancer Res; 1988 Jun; 48(12):3533-6. PubMed ID: 3370646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the human metabolism of iproplatin.
    Pendyala L; Krishnan BS; Walsh JR; Arakali AV; Cowens JW; Creaven PJ
    Cancer Chemother Pharmacol; 1989; 25(1):10-4. PubMed ID: 2590996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and metabolism of iproplatin in murine L1210 cells.
    Pendyala L; Walsh JR; Huq MM; Arakali AV; Cowens JW; Creaven PJ
    Cancer Chemother Pharmacol; 1989; 25(1):15-8. PubMed ID: 2590997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II).
    Harrison R; McAuliffe CA; Zaki A; Baer J; Sharma H; Smith A; Jackson H; Fox BW
    Cancer Chemother Pharmacol; 1983; 10(2):90-5. PubMed ID: 6682017
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.
    Owens SE; Thatcher N; Sharma H; Adam N; Harrison R; Smith A; Zaki A; Baer JC; McAuliffe CA; Crowther D
    Cancer Chemother Pharmacol; 1985; 14(3):253-7. PubMed ID: 3888431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.
    Eastman A
    Chem Biol Interact; 1987 Mar; 61(3):241-8. PubMed ID: 3568194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)].
    Chawla SP; Yap BS; Tenney DM; Bodey GP; Benjamin RS
    Invest New Drugs; 1988 Dec; 6(4):311-7. PubMed ID: 3229943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal function impairment of iproplatin pharmacokinetics and relation to toxicity.
    Pendyala L; Madajewicz S; Creaven PJ
    Cancer Res; 1985 Nov; 45(11 Pt 2):5936-8. PubMed ID: 4053065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the reactive form of the anticancer agent iproplatin.
    Volckova E; Weaver E; Bose RN
    Eur J Med Chem; 2008 May; 43(5):1081-4. PubMed ID: 17707553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.
    Pendyala L; Greco W; Cowens JW; Madajewicz S; Creaven PJ
    Cancer Chemother Pharmacol; 1983; 11(1):23-8. PubMed ID: 6883623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
    Pendyala L; Perez R; Weinstein A; Zdanowicz J; Creaven PJ
    Cancer Chemother Pharmacol; 1997; 40(1):38-44. PubMed ID: 9137527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog.
    Pendyala L; Cowens JW; Creaven PJ
    Cancer Treat Rep; 1982 Mar; 66(3):509-16. PubMed ID: 7060038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues.
    Murray V; Whittaker J; Temple MD; McFadyen WD
    Biochim Biophys Acta; 1997 Nov; 1354(3):261-71. PubMed ID: 9427535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of DNA strand breaks in Escherichia coli treated with platinum(IV) antitumor compounds.
    Defais M; Germanier M; Johnson NP
    Chem Biol Interact; 1990; 74(3):343-52. PubMed ID: 2112045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ; Barnard CF; Murrer BA; Kelland LR
    Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of two second generation platinum antitumor drugs with mouse thymocytes.
    Simpkins H; Pearlman LF
    Cancer Res; 1986 Mar; 46(3):1433-9. PubMed ID: 3510724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of sodium chloroplatinate and iproplatin with metallothionein in vivo.
    Zhong W; Zhang Q; Yan Y; Yue S; Zhang B; Tang W
    J Inorg Biochem; 1997 May; 66(3):159-64. PubMed ID: 9130391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence specificity and reactivity of the binding of phenazine-tethered platinum complexes to DNA.
    Perrin LC; Cullinane C; McFadyen WD; Phillips DR
    Anticancer Drug Des; 1999 Jun; 14(3):243-52. PubMed ID: 10500499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.